Breathe Well Live Well
|
Dynavax Technologies Corporation (DVAX): Dynavax Initiates Phase I Trial In …
Seeking Alpha After the close of the markets on Wednesday, October 9, 2013, Dynavax (DVAX) announced it will begin dosing patients in the first human trial in its asthma program. The trial, which is being conducted under a collaborative agreement with AstraZeneca … |
View full post on asthma – Google News
|
DYNAVAX TECHNOLOGIES CORPORATION : Dynavax Initiates First Human …
4-traders (press release) BERKELEY, CA — (Marketwired) — 10/09/13 — Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the start of dosing in the first human clinical trial in its asthma program. Dynavax is conducting the trial under its collaboration agreement … Dynavax starts Phase I trial of asthma treatment Dynavax Initiates First Human Trial in Asthma Program |
View full post on asthma – Google News
|
Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD
Reuters (press release) Nycomed / Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Nycomed announced today that it has … |
View full post on asthma – Google News